BEAM Alliance

Launched in June 2015, the BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) Alliance is a strong Network…

BioNTECH

In collaboration with the BioNTech Institute and the TrON Research Institute, the DZIF is researching RNA-based vaccines for…

CARB-X

CARB-X (Combating Antibiotic Resistant Biopharmaceutical Accelerator) is a funding organisation for projects in the field of…

Coalition for Epidemic Preparedness Innovations (CEPI)

The global community wants to be better prepared for serious infectious disease epidemics than before. For this purpose, the…

Coris BioConcept

The DZIF scientists from the Institute of Medical Microbiology at the University of Cologne have generated antibodies against…

Global AMR R&D Hub

The Global Antimicrobial Resistance Research and Development Hub, or Global AMR R&D Hub for short, is an initiative of…

HYpharm GmbH

HYpharm GmbH and a consortium funded by the DZIF are collaborating to manufacture and preclinically develop phage lytic…

Juno Therapeutics

Juno Therapeutics, formerly Stage Cell Therapeutics, is collaborating and exploitation partner of the research group led by…